1. Comparing cancer screening estimates: Behavioral Risk Factor Surveillance System and National Health Interview Survey
- Author
-
Benmei Liu, Ahmedin Jemal, Stacey A. Fedewa, Rebecca L. Siegel, and Ann Goding Sauer
- Subjects
Adult ,Male ,medicine.medical_specialty ,Epidemiology ,Colorectal cancer ,Uterine Cervical Neoplasms ,Breast Neoplasms ,Behavioral Risk Factor Surveillance System ,03 medical and health sciences ,0302 clinical medicine ,Breast cancer ,Cancer screening ,medicine ,Humans ,National Health Interview Survey ,030212 general & internal medicine ,Early Detection of Cancer ,Aged ,Cervical cancer ,Data source ,Cancer prevention ,business.industry ,Public Health, Environmental and Occupational Health ,Middle Aged ,medicine.disease ,Health Surveys ,030220 oncology & carcinogenesis ,Physical therapy ,population characteristics ,Female ,Colorectal Neoplasms ,business ,Demography - Abstract
Cancer screening prevalence from the Behavioral Risk Factor Surveillance System (BRFSS), designed to provide state-level estimates, and the National Health Interview Survey (NHIS), designed to provide national estimates, are used to measure progress in cancer control. A detailed description of the extent to which recent cancer screening estimates vary by key demographic characteristics has not been previously described. We examined national prevalence estimates for recommended breast, cervical, and colorectal cancer screening using data from the 2012 and 2014 BRFSS and the 2010 and 2013 NHIS. Treating the NHIS estimates as the reference, direct differences (DD) were calculated by subtracting NHIS estimates from BRFSS estimates. Relative differences were computed by dividing the DD by the NHIS estimates. Two-sample t-tests (2-tails), were performed to test for statistically significant differences. BRFSS screening estimates were higher than those from NHIS for breast (78.4% versus 72.5%; DD=5.9%, p
- Published
- 2018
- Full Text
- View/download PDF